The question facing healthcare leaders today is no longer whether Artificial Intelligence (AI) will be transformative, but whether our organizations can transform quickly enough to harness it at an enterprise …
Category:
Health
-
-
A growing number of Americans are paying thousands of dollars out of pocket for elective whole-body MRI scans, drawn by the promise of catching fatal diseases early. The companies offering …
-
Specialty care company Lantern and primary care provider Marathon Health introduced a new partnership on Thursday that aims to bring down specialty care spend for employers. Dallas, Texas-based Lantern directs …
-
Cardiovascular disease drugs continue to rank among the most prescribed medicines, but there’s still leave plenty of unmet medical need. Many of these products are one-size-fits all and they manage …
-
Cross-border structures in life sciences are no longer the exception; they are the rule. Whether it’s an Israeli biotech starting up a U.S. subsidiary to tap into the talent pipeline …
-
Two to three years ago, investors were telling startups that clinical coding would be fully automated by LLMs within a year — which didn’t quite turn out to be true. …
-
A new analysis from KFF shows that for the first time since the enhanced premium tax credits were introduced in 2021, insurer participation in the Affordable Care Act Marketplaces has …
-
The FDA now agrees uniQure’s clinical data for its Huntington’s disease gene therapy can support a regulatory submission in this rare neurodegenerative disorder, reversing its stance just a few months …
-
Health
Combined GI Procedures Are Becoming Routine – AI Can Help Address the Gap in Upper GI Quality Standards
Most patients who undergo a combined upper and lower GI endoscopy think of it as one procedure. In clinical terms, it is two: an esophagogastroduodenoscopy examining the upper tract, followed …
-
Prostate cancer can be treated with targeted therapies, but there are still opportunities to improve on this approach. MultiValent Biotherapies is going after two validated cancer targets with a single …